메뉴 건너뛰기




Volumn 40, Issue 6, 2012, Pages 457-465

Thrombomodulin enhances the antifibrinolytic and antileukemic effects of all-trans retinoic acid in acute promyelocytic leukemia cells

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; LIPOCORTIN 2; PLASMIN; PLASMINOGEN; PROTEIN C; RECOMBINANT THROMBOMODULIN; RETINOIC ACID; THROMBIN; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84862784002     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.016     Document Type: Article
Times cited : (18)

References (28)
  • 1
    • 0042027816 scopus 로고    scopus 로고
    • Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate
    • Ohno R., Asou N., Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 2003, 17:1454-1463.
    • (2003) Leukemia , vol.17 , pp. 1454-1463
    • Ohno, R.1    Asou, N.2    Ohnishi, K.3
  • 2
    • 19944432294 scopus 로고    scopus 로고
    • Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
    • Moll S., Lindley C., Pescatore S., et al. Phase I study of a novel recombinant human soluble thrombomodulin, ART-123. J Thromb Haemost 2004, 2:1745-1751.
    • (2004) J Thromb Haemost , vol.2 , pp. 1745-1751
    • Moll, S.1    Lindley, C.2    Pescatore, S.3
  • 3
    • 0023374585 scopus 로고
    • Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation
    • Suzuki K., Kusumoto H., Deyashiki Y., et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987, 6:1891-1897.
    • (1987) EMBO J , vol.6 , pp. 1891-1897
    • Suzuki, K.1    Kusumoto, H.2    Deyashiki, Y.3
  • 4
    • 0025174705 scopus 로고
    • Structure and function of thrombomodulin: a natural anticoagulant
    • Dittman W.A., Majerus P.W. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990, 75:329-336.
    • (1990) Blood , vol.75 , pp. 329-336
    • Dittman, W.A.1    Majerus, P.W.2
  • 5
    • 20444427991 scopus 로고    scopus 로고
    • The anticoagulation protein C pathway
    • Dahlback B., Villoutreix B.O. The anticoagulation protein C pathway. FEBS Lett 2005, 579:3310-3316.
    • (2005) FEBS Lett , vol.579 , pp. 3310-3316
    • Dahlback, B.1    Villoutreix, B.O.2
  • 6
    • 33845513582 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial
    • Saito H., Maruyama I., Shimazaki S., et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007, 5:31-41.
    • (2007) J Thromb Haemost , vol.5 , pp. 31-41
    • Saito, H.1    Maruyama, I.2    Shimazaki, S.3
  • 7
    • 77956265194 scopus 로고    scopus 로고
    • Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC
    • Ikezoe T., Ikenoue N., Uchikawa N., Kojima S., Fukaya T., Yokoyama A. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC. Thromb Res 2010, 126:e238-e240.
    • (2010) Thromb Res , vol.126
    • Ikezoe, T.1    Ikenoue, N.2    Uchikawa, N.3    Kojima, S.4    Fukaya, T.5    Yokoyama, A.6
  • 8
    • 78149280175 scopus 로고    scopus 로고
    • Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin
    • Sakai M., Ikezoe T., Bandobashi K., Yokoyama A. Successful treatment of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with recombinant human soluble thrombomodulin. Thromb Res 2010, 126:e392-e393.
    • (2010) Thromb Res , vol.126
    • Sakai, M.1    Ikezoe, T.2    Bandobashi, K.3    Yokoyama, A.4
  • 9
    • 77950628343 scopus 로고    scopus 로고
    • Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin
    • Sakai M., Ikezoe T., Bandobashi K., Togitani K., Yokoyama A. Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin. Bone Marrow Transplant 2010, 45:803-805.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 803-805
    • Sakai, M.1    Ikezoe, T.2    Bandobashi, K.3    Togitani, K.4    Yokoyama, A.5
  • 10
    • 77950624556 scopus 로고    scopus 로고
    • Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
    • Ikezoe T., Togitani K., Komatsu N., Isaka M., Yokoyama A. Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Bone Marrow Transplant 2010, 45:783-785.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 783-785
    • Ikezoe, T.1    Togitani, K.2    Komatsu, N.3    Isaka, M.4    Yokoyama, A.5
  • 11
    • 79953703447 scopus 로고    scopus 로고
    • Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome
    • Ikezoe T., Takeuchi A., Taniguchi A., Togitani K., Yokoyama A. Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome. Bone Marrow Transplant 2011, 46:616-618.
    • (2011) Bone Marrow Transplant , vol.46 , pp. 616-618
    • Ikezoe, T.1    Takeuchi, A.2    Taniguchi, A.3    Togitani, K.4    Yokoyama, A.5
  • 12
    • 0030861004 scopus 로고    scopus 로고
    • Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study
    • Kim S.J., Shiba E., Ishii H., et al. Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study. Anticancer Res 1997, 17:2319-2323.
    • (1997) Anticancer Res , vol.17 , pp. 2319-2323
    • Kim, S.J.1    Shiba, E.2    Ishii, H.3
  • 13
    • 33646496599 scopus 로고    scopus 로고
    • Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival
    • Hanly A.M., Redmond M., Winter D.C., et al. Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer 2006, 94:1320-1325.
    • (2006) Br J Cancer , vol.94 , pp. 1320-1325
    • Hanly, A.M.1    Redmond, M.2    Winter, D.C.3
  • 14
    • 77958127758 scopus 로고    scopus 로고
    • Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer
    • Liu P.L., Tsai J.R., Chiu C.C., et al. Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer. Mol Carcinog 2010, 49:874-881.
    • (2010) Mol Carcinog , vol.49 , pp. 874-881
    • Liu, P.L.1    Tsai, J.R.2    Chiu, C.C.3
  • 15
    • 0000686636 scopus 로고    scopus 로고
    • Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity
    • Zhang Y., Weiler-Guettler H., Chen J., et al. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest 1998, 101:1301-1309.
    • (1998) J Clin Invest , vol.101 , pp. 1301-1309
    • Zhang, Y.1    Weiler-Guettler, H.2    Chen, J.3
  • 16
    • 34250771649 scopus 로고    scopus 로고
    • A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
    • Ikezoe T., Yang J., Nishioka C., et al. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol Cancer Ther 2007, 6:1851-1857.
    • (2007) Mol Cancer Ther , vol.6 , pp. 1851-1857
    • Ikezoe, T.1    Yang, J.2    Nishioka, C.3
  • 17
    • 33744830869 scopus 로고    scopus 로고
    • HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24
    • Ikezoe T., Bandobashi K., Yang Y., et al. HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24. Leuk Res 2006, 30:1005-1011.
    • (2006) Leuk Res , vol.30 , pp. 1005-1011
    • Ikezoe, T.1    Bandobashi, K.2    Yang, Y.3
  • 18
    • 68549083470 scopus 로고    scopus 로고
    • Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells
    • Nishioka C., Ikezoe T., Yang J., Gery S., Koeffler H.P., Yokoyama A. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. Int J Cancer 2009, 125:1710-1720.
    • (2009) Int J Cancer , vol.125 , pp. 1710-1720
    • Nishioka, C.1    Ikezoe, T.2    Yang, J.3    Gery, S.4    Koeffler, H.P.5    Yokoyama, A.6
  • 19
    • 0034669985 scopus 로고    scopus 로고
    • HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells
    • Ikezoe T., Daar E.S., Hisatake J., Taguchi H., Koeffler H.P. HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. Blood 2000, 96:3553-3559.
    • (2000) Blood , vol.96 , pp. 3553-3559
    • Ikezoe, T.1    Daar, E.S.2    Hisatake, J.3    Taguchi, H.4    Koeffler, H.P.5
  • 20
    • 3042751482 scopus 로고    scopus 로고
    • Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells
    • Ikezoe T., Tanosaki S., Krug U., et al. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood 2004, 104:237-242.
    • (2004) Blood , vol.104 , pp. 237-242
    • Ikezoe, T.1    Tanosaki, S.2    Krug, U.3
  • 21
    • 33750483896 scopus 로고    scopus 로고
    • The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling
    • Ikezoe T., Nishioka C., Tasaka T., et al. The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling. Mol Cancer Ther 2006, 5:2522-2530.
    • (2006) Mol Cancer Ther , vol.5 , pp. 2522-2530
    • Ikezoe, T.1    Nishioka, C.2    Tasaka, T.3
  • 22
    • 62149108968 scopus 로고    scopus 로고
    • Soluble thrombomodulin protects ischemic kidneys
    • Sharfuddin A.A., Sandoval R.M., Berg D.T., et al. Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 2009, 20:524-534.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 524-534
    • Sharfuddin, A.A.1    Sandoval, R.M.2    Berg, D.T.3
  • 23
    • 0027411150 scopus 로고
    • Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity
    • Nagashima M., Lundh E., Leonard J.C., Morser J., Parkinson J.F. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem 1993, 268:2888-2892.
    • (1993) J Biol Chem , vol.268 , pp. 2888-2892
    • Nagashima, M.1    Lundh, E.2    Leonard, J.C.3    Morser, J.4    Parkinson, J.F.5
  • 25
    • 0029050715 scopus 로고
    • The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells
    • Hamada H., Ishii H., Sakyo K., Horie S., Nishiki K., Kazama M. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells. Blood 1995, 86:225-233.
    • (1995) Blood , vol.86 , pp. 225-233
    • Hamada, H.1    Ishii, H.2    Sakyo, K.3    Horie, S.4    Nishiki, K.5    Kazama, M.6
  • 26
    • 36148996511 scopus 로고    scopus 로고
    • Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon
    • Binette T.M., Taylor F.B., Peer G., Bajzar L. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Blood 2007, 110:3168-3175.
    • (2007) Blood , vol.110 , pp. 3168-3175
    • Binette, T.M.1    Taylor, F.B.2    Peer, G.3    Bajzar, L.4
  • 27
    • 0026573536 scopus 로고
    • Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP
    • Horie S., Kizaki K., Ishii H., Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP. Biochem J 1992, 281:149-154.
    • (1992) Biochem J , vol.281 , pp. 149-154
    • Horie, S.1    Kizaki, K.2    Ishii, H.3    Kazama, M.4
  • 28
    • 0028145137 scopus 로고
    • Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells
    • Kizaki K., Ishii H., Horie S., Kazama M. Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells. Thromb Haemost 1994, 72:573-577.
    • (1994) Thromb Haemost , vol.72 , pp. 573-577
    • Kizaki, K.1    Ishii, H.2    Horie, S.3    Kazama, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.